Report overview
The material of the degradable stent is polylactic acid, etc., which can be completely degraded within 2-3 years after implantation in the body, and can restore the function and elasticity of blood vessels without permanent retention.
This report aims to provide a comprehensive presentation of the global market for Fully Bioresorbable Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fully Bioresorbable Stents. This report contains market size and forecasts of Fully Bioresorbable Stents in global, including the following market information:
Global Fully Bioresorbable Stents Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Fully Bioresorbable Stents Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Fully Bioresorbable Stents companies in 2022 (%)
The global Fully Bioresorbable Stents market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Below 100?m Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fully Bioresorbable Stents include Abbott, Lepu Medical Technology, Shandong Hua'an Biotechnology, MicroPort, Lifetech Scientific, Beijing Advanced Medical Technologies, Shanghai Bio-heart Biological Technology, Elixir Medical Corporation and Biotronic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fully Bioresorbable Stents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fully Bioresorbable Stents Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Fully Bioresorbable Stents Market Segment Percentages, by Type, 2022 (%)
Below 100?m
100-150?m
More than 150?m
Global Fully Bioresorbable Stents Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Fully Bioresorbable Stents Market Segment Percentages, by Application, 2022 (%)
Hospital
Surgical Centers
Others
Global Fully Bioresorbable Stents Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Fully Bioresorbable Stents Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fully Bioresorbable Stents revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Fully Bioresorbable Stents revenues share in global market, 2022 (%)
Key companies Fully Bioresorbable Stents sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Fully Bioresorbable Stents sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Lepu Medical Technology
Shandong Hua'an Biotechnology
MicroPort
Lifetech Scientific
Beijing Advanced Medical Technologies
Shanghai Bio-heart Biological Technology
Elixir Medical Corporation
Biotronic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fully Bioresorbable Stents, market overview.
Chapter 2: Global Fully Bioresorbable Stents market size in revenue and volume.
Chapter 3: Detailed analysis of Fully Bioresorbable Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fully Bioresorbable Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fully Bioresorbable Stents capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
